Track Pfizer Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Pfizer Inc. PFE.F · Stock Open Pfizer Inc. in new tab

25.05 EUR
P/E
38.02
EPS
0.65
Yield
6.32%
Safety Score
21
P/B
1.86
ROE
5.01
Beta
0.28
Loading chart...
Key Metrics
Earnings dateNov. 3, 2026
P/E38.02
EPS0.65
Book Value13.28
Price to Book1.86
Debt/Equity74.25
% Insiders0.104%
Growth
Revenue Growth0.03%
Earnings Growth-0.10%
Dividend
Dividend Yield6.32%
Annual dividends1.72 EUR
Ex-Div. DateNov. 6, 2026
Payout225.72%
5y avg Yield4.54%

DCF Valuation

Tweak assumptions to recompute fair value for Pfizer Inc. (PFE.F)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Pfizer Inc. Logo Pfizer Inc. Analysis (PFE.F)

United States Health Care Official Website Stock

Is Pfizer Inc. a good investment? Pfizer Inc. (PFE.F) is currently trading at 25.05 EUR.

In terms of valuation, the stock trades at a P/E ratio of 38.02. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Pfizer Inc. is expected to release its next earnings report on Nov. 3, 2026.

For income investors, Pfizer Inc. pays a dividend yield of 6.32%. With a payout ratio of 226%, the dividend appears to be under pressure.

Investor FAQ

Does Pfizer Inc. pay a dividend?

Yes, it pays an annual dividend of 1.72 EUR (6.32% yield).

What asset class is Pfizer Inc.?

Pfizer Inc. is classified as a Stock. You can compare it against 12 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Nov. 3, 2026. The company currently has a trailing EPS of 0.65.

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Exchange Ticker
MEX (Mexico) PFE.MX
HAN (Germany) PFE.HA
SGO (Chile) PFE.SN
HAM (Germany) PFE.HM
BER (Germany) PFE.BE
STO (Sweden) PFE.ST
VIE (Austria) PFE.VI
STU (Germany) PFE.SG
DUS (Germany) PFE.DU
GER (Germany) PFE.DE
NYQ (United States) PFE
FRA (Germany) PFE.F
Trades
Dividend Yield
6.32%
5y avg 4.54%
Annual Dividends
1.72EUR
Next Ex. Div Date
Nov. 6, 2026
Payout Ratio
225.72%
Dividend History paid per year (EUR)
Historical Dividends
Year Total Dividends
▸2027
1.14 EUR
Sept. 1, 2027 (estimated) 0.3797
June 1, 2027 (estimated) 0.3797
March 1, 2027 (estimated) 0.3797
▸2026
1.49 EUR
Dec. 7, 2026 0.3819
Sept. 1, 2026 0.3703
June 12, 2026 0.3703
March 6, 2026 0.3703
▸2025
1.48 EUR
Dec. 1, 2025 0.3703
Sept. 2, 2025 0.3703
June 13, 2025 0.3703
March 7, 2025 0.3703
▸2024
1.45 EUR
Dec. 2, 2024 0.3617
Sept. 3, 2024 0.3617
June 14, 2024 0.3617
March 1, 2024 0.3617
▸2023
1.41 EUR
Dec. 4, 2023 0.3531
Sept. 5, 2023 0.3531
June 9, 2023 0.3531
March 3, 2023 0.3531
▸2022
1.38 EUR
Dec. 5, 2022 0.3445
Sept. 6, 2022 0.3445
June 10, 2022 0.3445
March 4, 2022 0.3445
▸2021
1.34 EUR
Dec. 6, 2021 0.3359
Sept. 7, 2021 0.3359
June 4, 2021 0.3359
March 5, 2021 0.3359
▸2020
1.31 EUR
Dec. 1, 2020 0.3273
Sept. 1, 2020 0.3273
June 5, 2020 0.3273
March 6, 2020 0.3273
▸2019
1.57 EUR
Dec. 2, 2019 0.3100
Sept. 3, 2019 0.3100
July 31, 2019 0.3334
June 7, 2019 0.3100
March 1, 2019 0.3100
▸2018
1.49 EUR
Dec. 3, 2018 0.2928
Sept. 4, 2018 0.2928
June 1, 2018 0.2928
March 1, 2018 0.2928
Jan. 31, 2018 0.3148
▸2017
1.12 EUR
Sept. 1, 2017 0.2756
June 1, 2017 0.2756
March 1, 2017 0.2756
Jan. 31, 2017 0.2963
▸2016
0.78 EUR
Nov. 8, 2016 0.2584
Aug. 3, 2016 0.2584
Feb. 3, 2016 0.2584
▸2015
0.96 EUR
Nov. 4, 2015 0.2411
Aug. 5, 2015 0.2411
May 6, 2015 0.2411
Feb. 4, 2015 0.2411
▸2014
0.90 EUR
Nov. 5, 2014 0.2239
July 30, 2014 0.2239
May 7, 2014 0.2239
Feb. 5, 2014 0.2239
▸2013
0.83 EUR
Nov. 6, 2013 0.2067
July 31, 2013 0.2067
May 8, 2013 0.2067
Jan. 30, 2013 0.2067
▸2012
1.17 EUR
Nov. 7, 2012 0.1895
Aug. 1, 2012 0.1895
July 31, 2012 0.2037
May 9, 2012 0.1895
Feb. 1, 2012 0.1895
Jan. 31, 2012 0.2037
▸2011
0.69 EUR
Nov. 8, 2011 0.1722
Aug. 3, 2011 0.1722
May 11, 2011 0.1722
Feb. 2, 2011 0.1722
▸2010
0.31 EUR
Nov. 4, 2010 0.1550
Aug. 4, 2010 0.1550
Upcoming Dividends
Name Payment Date Status Amount
Pfizer Inc. Dec 07, 2026 Upcoming 0.38193 EUR
Pfizer Inc. Sep 01, 2026 0.370316 EUR
Pfizer Inc. Jun 12, 2026 0.370316 EUR
Pfizer Inc. Mar 06, 2026 0.370316 EUR
Pfizer Inc. Dec 01, 2025 0.370316 EUR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion